The Sarepta Therapeutics, Inc. (NASDAQ:SRPT) Upgraded to "Buy" at BidaskClub

Claudine Rigal
Juillet 17, 2017

Hudson Bay Cap Mgmt Lp has 167,091 shares for 0.1% of their portfolio. The biotechnology company reported ($0.73) EPS for the quarter, beating analysts' consensus estimates of ($0.85) by $0.12. The stock had a trading volume of 1,261,202 shares. It has outperformed by 80.12% the S&P500. Sarepta Therapeutics Inc now has $1.96 billion valuation. During the same quarter in the previous year, the company posted ($1.15) EPS. Two Creeks Capital Management Lp who had been investing in Tempur Sealy Intl Inc for a number of months, seems to be bullish on the $2.77B market cap company. The stock rose 2.43% or $0.83 reaching $35.02.

Price T Rowe Associates Inc Md holds 381,173 shares. It has underperformed by 3.76% the S&P500. The Perceptive Advisors Llc holds 10,900 shares with $249,000 value, down from 3.40 million last quarter. Six investment analysts have rated the stock with a hold rating, sixteen have issued a buy rating and one has issued a strong buy rating to the stock. Therefore 47% are positive. Needham has "Buy" rating and $81 target. Tempur Sealy International Inc had 33 analyst reports since August 3, 2015 according to SRatingsIntel. The rating was downgraded by Macquarie Research to "Neutral" on Friday, May 19. The stock has "Hold" rating by Jefferies on Monday, September 19. Deutsche Bank maintained the stock with "Hold" rating in Wednesday, February 24 report. Viacom, Inc. (NASDAQ:VIAB) has declined 8.36% since July 14, 2016 and is downtrending. The firm has "Sector Perform" rating by RBC Capital Markets given on Thursday, July 30. Morgan Stanley maintained the shares of SRPT in report on Wednesday, January 4 with "Equal-Weight" rating.

Investors sentiment increased to 0.73 in Q4 2016. Its down 0.14, from 1.3 in 2016Q3. Renaissance Technologies Ltd Liability invested in 0.05% or 1.56 million shares. 48 funds opened positions while 76 raised stakes. Next Financial Gp Incorporated invested in 1,000 shares. Tower Research Lc (Trc) holds 0.01% or 4,811 shares in its portfolio. Group accumulated 24,574 shares or 0% of the stock. Janney Montgomery Scott Limited Liability Com accumulated 0.01% or 16,246 shares. Peddock Advisors Ltd Liability Corp owns 54 shares. Metropolitan Life Ins Ny has 49,280 shares. 735 were reported by North Star Invest Management Corporation. Raymond James Tru Na has invested 0.18% of its portfolio in Goldman Sachs Group Inc (NYSE:GS). Rock Springs Capital Mngmt Ltd Partnership reported 191,900 shares. Principal Gru, Iowa-based fund reported 34,334 shares. Granahan Invest Management Inc Ma has invested 0.33% in Pandora Media Inc (NYSE:P). Bnp Paribas Prns has 6,584 shares. 3,000 shares were sold by MARTIN CHRISTOPHER DOUGLAS, worth $34,950. WESTON GRAHAM M bought $2.00M worth of stock. Css Limited Liability Il owns 10,400 shares.

The stock of Cullen Frost Bankers, Inc. News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sarepta Therapeutics, Inc. with's FREE daily email newsletter. They expect $-0.91 EPS, up 32.09% or $0.43 from last year's $-1.34 per share.

06/29/2017 - Sarepta Therapeutics, Inc. had its " rating reiterated by analysts at Leerink Swann.

More notable recent Sarepta Therapeutics Inc (NASDAQ:SRPT) news were published by: which released: "Sarepta Therapeutics and Genethon Announce a Gene Therapy Research ..." on June 21, 2017, also with their article: "Sarepta Therapeutics names new CEO" published on June 28, 2017, published: "Why Sarepta Therapeutics Stock Picked Up Steam in June" on July 12, 2017.

Investors sentiment decreased to 1.07 in 2016 Q4. Its down 0.45, from 1.52 in 2016Q3. It improved, as 65 investors sold GS shares while 424 reduced holdings. 39 funds opened positions while 55 raised stakes. Clearbridge Invests Ltd Company reported 3,806 shares.

Sarepta Therapeutics (NASDAQ SRPT) remained flat at $35.25 on Friday. Zurcher Kantonalbank (Zurich Cantonalbank) accumulated 1,289 shares. Fin Architects reported 5 shares. Glenmede Trust Na accumulated 0% or 2,000 shares. Sterling Cap Mngmt Ltd Liability reported 9,205 shares. Baker Avenue Asset Mngmt Lp has 18,531 shares. The stock of Sarepta Therapeutics Inc (NASDAQ:SRPT) earned "Neutral" rating by SunTrust on Tuesday, September 1. Blackrock Advsrs Ltd has 0.03% invested in Sarepta Therapeutics Inc (NASDAQ:SRPT). Fred Alger Mgmt Inc reported 125,302 shares. Sg Americas Secs Ltd Limited Liability Company reported 0.01% stake. Blackrock Grp Limited stated it has 0.01% in Sarepta Therapeutics Inc (NASDAQ:SRPT).

COPYRIGHT VIOLATION WARNING: "Sarepta Therapeutics, Inc". Cowen and Company restated a "buy" rating on shares of Sarepta Therapeutics in a research report on Friday, April 28th. Therefore 71% are positive. Meridian Interstate Bancorp had 4 analyst reports since September 30, 2015 according to SRatingsIntel. The rating was downgraded by William Blair on Thursday, April 21 to "Market Perform". As per Thursday, August 20, the company rating was maintained by Roth Capital. Credit Suisse initiated the stock with "Outperform" rating in Tuesday, October 18 report. On Wednesday, December 14 the stock rating was maintained by Jefferies with "Hold". Finally, Piper Jaffray Companies set a $43.00 price objective on Sarepta Therapeutics and gave the stock a "buy" rating in a research report on Thursday, May 18th. The firm has "Outperform" rating by RBC Capital Markets given on Wednesday, March 1. The firm earned "Outperform" rating on Friday, February 12 by FBR Capital. RBC Capital Markets maintained Cullen Frost Bankers, Inc. Finally, Creative Planning increased its position in shares of Sarepta Therapeutics by 11.9% in the first quarter.

D'autres rapports CampDesrEcrues

Discuter de cet article